Upload
leon-ethan-crawford
View
219
Download
1
Embed Size (px)
Citation preview
Appalachian Cardiovascular Research Network (ACoRN)
•Donald A. Primerano, Director• Investigators at graduate and undergraduate institutions•Funded through NCRR WV-INBRE grant •Part 1: ACoRN•Part 2: Problems and Solutions to patient Recruitment
ACoRN OVERALL GOALS
Scientific Goal: Discover genes that cause or predispose to cardiovascular disease
Programmatic Goals:
(1) use multidisciplinary approaches to dissect complex cardiovascular diseases(2) provide training in genetic analysis(3) provide access to human data and samples to network investigators
Cardiovascular Disease in the US
Coronary artery disease (CAD) accounts for 27% of all deaths
Although declining, still the leading cause of death in the United States
US average rate: 240.8/100,000*
*Kaiser Family Foundation (2002) Causes of death attributable to heart disease mortality include ICD-10 Codes I00-I09; I11; I13; I20-I51.
Cardiovascular Disease in WV
• Among the 50 states:
• 5th in deaths due to heart disease (288 deaths/100,000)
• 2nd in obesity (25% BMI >30)
• 1st in overweight (61% BMI>25)
*Kaiser Family Foundation (2002)
Complex genetic diseases (multifactorial inheritance)
“run in families” but clearly nonMendelian Phenotype: one or more genes plus
environmental factors Complex diseases are present at higher
population frequency AND therefore a greater public health concern
Complex disease success stories: Alzheimer’s disease (linkage analysis) Age Related Macular Degeneration (GWAS)
Gene Mapping StudiesBasic Premises
An allele of a given gene causes or confers susceptibility to a particular disease state
The presence of the disease state in a patient means that the disease allele is present.
Co-segregation of the disease allele with a genetic marker gives the genetic position of the disease gene Linkage analysis or Linkage Disequilibrium studies
Genetic location + gene expression data + human genome sequence = identification of disease gene
ACoRN Approaches
• Two Overlapping Networks: • (1) Researchers • (2) Clinicians at hospitals and rural clinics
• Recruiting individuals and families into genetic studies
• Barriers• Some solutions and success stories
Network 1: ACoRN Researchers
CURRENT GENETICISTS: PLAN, ASCERTAINMENT PHYSICIANS: IDENTIFY CV AFFECTEDS DATABASE MANAGERS: DATA COLLECTION
AND SHARING STATISTICIANS (GENETIC ANALYSTS): MAP
LOCATION OF DISEASE GENES MOLECULAR BIOLOGISTS: USE MAP INFO TO
IDENTIFY DISEASE GENE AND DETERMINE ITS ROLE IN PATHOGENESIS
ACoRN Research Team CARDIOLOGISTS:
William Neal MD WVU HSC (CARDIAC program) Todd Gress MD MU Internal Medicine Ganpat Thakker MD CAMC Cardiovascular Services
DATABASE MANAGER: James Denvir PhD, Marshall University
GENETIC ANALYSTS: Yulia Dementieva PhD, Marshall University Huey-Miin Lee PhD, West Virginia University*
MOLECULAR GENETICISTS: Mark Flood PhD, Fairmont State University* Robert Kreisberg PhD, West Liberty State College* Liping Wei MS, MU Genomics Core Manager
Familial Combined Hyperlipidemia (FCHL)
FCH affecteds have elevated levels of both cholesterol and triglycerides.
FCH affects 1-2% of the population of Westernized societies
One of the most common genetic lipid disorders in patients with coronary artery disease.
Oligogenic disease Genome-wide linkage analyses point to
at least three different genetic loci
FCH Goals and Objectives FCH Long-Range Goal
Understand the molecular and cellular events that lead to disregulation of cholesterol and triglyceride levels
how these events predispose to atherosclerosis.
Objective of this project Identify gene(s) that predispose to FCH using
family-based linkage analysis family-based association (linkage disequilibrium) reliance on juvenile probands
Initial Plan for FCH Patient Recruitment
Define affected phenotype for adult and juvenile probands.
Obtain IRB approval for chart reviews and recruitment at multiple sites.
Conduct clinic chart reviews and review statewide CARDIAC database.
Contact potential probands by phone or letter or both.
Interested participants and their relatives come to the clinic sign consent, give blood sample and family history.
Network #2Participant Recruitment (6 Sites)
Three Largest Cardio Centers in WV Charleston Area Medical Center WVU Health Science Center Marshall University Internal Medicine
Three Rural Clinics Lincoln Primary Care Center Valley Health Systems Tug River Clinic
FCH PATIENT RECRUITMENT
Statewide CARDIAC Project: a population-based screening program designed to raise awareness of CAD risk factors and identify individuals at high risk for premature CAD.
Director: William Neal, MD > 10,000 5th grade students/yr are screened for
BMI, BP and blood cholesterol levels. 1% (100/yr) may be affected juvenile probands FCHL families
FCH juvenile probands
5th-12th grade students,9-18 years of age
(1) fasting total cholesterol >230mg/dl(2) fasting LDL > 150mg/dl (3) fasting triglycerides > 150 mg/dl (4) fasting HDL < 35 mg/dl
Patient Recruitment: Some Barriers (I)
WV is the third most rural state long commutes to medical centers low average income large elderly population
Mistrust of genetic studies Family or community might be labeled matriarch/patriarch gets the “blame” risk of loss of insurance coverage unwanted notoriety
Patient Recruitment: Some Barriers (II)
Fasting requirement Exclusion criteria Missing work to come to clinic Need the whole family to participate Limited short-term benefit to genetic
studies We provide lipid panel data to physician
and/or patient but none of the genetic findings
“Rural Cancer Patients’ Perspectives on Clinical Trials: A Qualitative Study”
Interviews with 17 cancer patients in rural WV Few patients had knowledge of clinical trials. Findings: Treatment location, MD’s input,
disease status and perceived effectiveness influenced decision making process.
Patients should be better informed about the nature of clinical trials.
Physician trust may enhance participation Coyne et al, J. Cancer Education 19:165-169
2004
Patient Recruitment: Solutions (1)
Getting Families Interested: Critical input and assurances from the specialist, family
doctor and the nurse at a regular clinic appointment Doctor-patient relationship is critical
Finding Interested Families CARDIAC program involves children and parents, so
whole families are identified Alliances with other Appalachia states (e.g. Kentucky
INBRE program) Access to electronic databases
Need special permission for some clinical networks
Patient Recruitment: Solutions (2)
Go The Distance Doctor, nurse-phlebotomist, and geneticist
all go to a central location on a mutually agreed upon Saturday.
Gift cards for enrollees are helpful Explain Significance of the Study
Importance of early diagnosis of disease and treatment must be stressed
Tell prospective participants about data safeguards
Patient Recruitment: Solutions (3)
Getting physicians interested Physicians are overwhelmed with patient
load in some settings. Visiting speakers can provide updates on
the basic/clinical science and improve the understanding of the need for the study.
Getting the community involved Health fairs Community Health Educators Direct collaborations with providers
FCH Status Report Three IRB protocols in place:
MU, WVU and CAMC (+ three rural clinics) Central statewide IRB panel would reduce admin load
LabCorp performs serum lipid profiles Accept samples by FEDEX Send data back by email
Three large families have been enrolled through the CARDIAC program.
Four smaller families through CAMC and MU. Total enrollment = ~70 participants.
SUMMARY Significant barriers exist in carrying out
genetic studies on Appalachian populations. Motivated physicians and nurses are critical to
many aspects. Geographic isolation can be partly resolved by
“traveling teams”. Basic scientist updates major and rural sites
on medical advances. Several studies suggest that community
meetings may be helpful.